Sabre appoints Constellation Software exec to board; ends poison pill

Sabre Corp

Appoints Damian McKay (CEO Vela Software, Constellation division) to Sabre board; effective within 10 business days.
Constellation holds ~12.7% of Sabre shares; standstill caps ownership at 15% during specified period.
Sabre terminates March 1, 2026 shareholder rights plan (poison pill); expiration accelerated to close on March 6, 2026.
Constellation withdraws prior director nomination notice; parties agree to mutual non-disparagement and confidentiality.
McKay will serve on Technology Committee; receives annual cash retainer of $90,000 plus equity awards.

item 1.01item 5.02item 1.02item 3.03item 5.03item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.